Epiliquid
PrivateLast Round
Accelerator
Feb 18, 2025
Company Overview
Epiliquid operates in Healthcare & Life Sciences and is based in Mendoza. Its latest recorded funding round was an Accelerator round in February 2025.
Epiliquid is a biotechnology company that develops a liquid biopsy platform for early cancer detection using epigenetic biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epiliquid Comparables
Compare Epiliquid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singlera Genomics Inc. | 77% | |
| Harbinger Health | 77% | |
| Delfi Diagnostics | 77% |
For institutional investors. Book with your work email.
Epiliquid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 18, 2025 | ||||
| Grant | Sep 13, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epiliquid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITES | Seed |
| Johnson & Johnson Foundation | Accelerator |
| Village Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 156% MoM, from 85 to 218.
- May 3, 2025
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
Epiliquid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epiliquid's valuation, stock price, and market status.
Is Epiliquid a public or private company?
Epiliquid is a private company.
What is the current stock price of Epiliquid?
Epiliquid is a private company, so its shares have no public market price. Caplight tracks Epiliquid's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epiliquid worth (valuation)?
Valuation information for Epiliquid is not publicly available.
Can I buy Epiliquid stock?
Epiliquid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epiliquid's last funding round?
Epiliquid's most recent funding round was Accelerator on February 18, 2025.
Who are the main investors in Epiliquid?
Key investors in Epiliquid include CITES, Johnson & Johnson Foundation, Village Capital.
Will Epiliquid IPO soon?
No public IPO plans have been announced for Epiliquid.
How can I track Epiliquid secondary market activity?
Caplight tracks bids, offers, and trades in Epiliquid's shares on secondary markets.